ZELRISIG Trademark

Trademark Overview

On Tuesday, August 26, 2014, a trademark application was filed for ZELRISIG with the United States Patent and Trademark Office. The USPTO has given the ZELRISIG trademark a serial number of 86376846. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 23, 2018. This trademark is owned by Glaxo Group Limited. The ZELRISIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
zelrisig

General Information

Serial Number86376846
Word MarkZELRISIG
Filing DateTuesday, August 26, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 23, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 8, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, April 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2017EXTENSION 5 GRANTED
Thursday, August 24, 2017EXTENSION 5 FILED
Friday, September 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 24, 2017TEAS EXTENSION RECEIVED
Thursday, March 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2017EXTENSION 4 GRANTED
Tuesday, March 14, 2017EXTENSION 4 FILED
Tuesday, March 14, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2016EXTENSION 3 GRANTED
Monday, September 12, 2016EXTENSION 3 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Tuesday, April 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 11, 2016EXTENSION 2 GRANTED
Thursday, March 3, 2016EXTENSION 2 FILED
Tuesday, April 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2016TEAS EXTENSION RECEIVED
Friday, July 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 29, 2015EXTENSION 1 GRANTED
Wednesday, July 29, 2015EXTENSION 1 FILED
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 20, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 31, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 29, 2014ASSIGNED TO EXAMINER
Monday, September 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 29, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

zelrisig pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological